UTHR insider transactions
United Therapeutics Corporation (UTHR) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for UTHR
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $4,863,730 worth of shares (9,500 units at $511.97) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $4,924,666 worth of shares (9,500 units at $518.39) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $4,949,717 worth of shares (9,500 units at $521.02) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- EVP & GENERAL COUNSEL Mahon Paul A exercised 8,300 shares at a strike of $146.03 and sold $4,342,079 worth of shares (8,300 units at $523.14) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $5,006,104 worth of shares (9,500 units at $526.96) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $4,898,221 worth of shares (9,500 units at $515.60) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $4,812,568 worth of shares (9,500 units at $506.59) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $4,739,664 worth of shares (9,500 units at $498.91) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $4,790,316 worth of shares (9,500 units at $504.24) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $4,892,748 worth of shares (9,500 units at $515.03) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A sold $4,967,292 worth of shares (9,500 units at $522.87) as part of a pre-agreed trading plan and exercised 9,500 shares at a strike of $135.42 (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $5,036,073 worth of shares (9,500 units at $530.11) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $5,048,137 worth of shares (9,500 units at $531.38) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $4,990,873 worth of shares (9,500 units at $525.36) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- EVP & GENERAL COUNSEL Mahon Paul A sold $4,291,512 worth of shares (8,300 units at $517.05) as part of a pre-agreed trading plan and exercised 8,300 shares at a strike of $146.03 (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $4,927,985 worth of shares (9,500 units at $518.74) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $4,912,310 worth of shares (9,500 units at $517.09) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A sold $4,902,569 worth of shares (9,500 units at $516.06) as part of a pre-agreed trading plan and exercised 9,500 shares at a strike of $135.42 (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $4,930,098 worth of shares (9,500 units at $518.96) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $4,986,594 worth of shares (9,500 units at $524.90) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A sold $4,962,488 worth of shares (9,500 units at $522.37) as part of a pre-agreed trading plan and exercised 9,500 shares at a strike of $135.42 (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $5,003,976 worth of shares (9,500 units at $526.73) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $5,038,971 worth of shares (9,500 units at $530.42) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $5,051,519 worth of shares (9,500 units at $531.74) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $5,021,520 worth of shares (9,500 units at $528.58) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- SEC Form 4 filed by Director Dzau Victor J4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- SEC Form 3 filed by new insider Dzau Victor J3 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- SEC Form 4 filed by Director Maxwell Linda4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- SEC Form 4 filed by Director Thompson Tommy G4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- SEC Form 4 filed by Director Tracey Kevin4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- SEC Form 4 filed by Director Olian Judy D.4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- SEC Form 4 filed by Director Malcolm Jan4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- SEC Form 4 filed by Director Mesa Nilda4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- SEC Form 4 filed by Director Sullivan Louis W4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- SEC Form 4 filed by Director Causey Christopher4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- SEC Form 4 filed by Director Patusky Christopher4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- SEC Form 4 filed by Director Giltner Richard4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- SEC Form 4 filed by Director Kurzweil Ray4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $5,040,380 worth of shares (9,500 units at $530.57) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $5,056,298 worth of shares (9,500 units at $532.24) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $5,051,035 worth of shares (9,500 units at $531.69) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $5,101,939 worth of shares (9,500 units at $537.05) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $5,043,689 worth of shares (9,500 units at $530.91) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $5,038,340 worth of shares (9,500 units at $530.35) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- EVP & GENERAL COUNSEL Mahon Paul A exercised 8,300 shares at a strike of $146.03 and sold $4,429,638 worth of shares (8,300 units at $533.69) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A sold $5,004,909 worth of shares (9,500 units at $526.83) as part of a pre-agreed trading plan and exercised 9,500 shares at a strike of $135.42 (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A sold $5,091,949 worth of shares (9,500 units at $535.99) as part of a pre-agreed trading plan and exercised 9,500 shares at a strike of $135.42 (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Director Giltner Richard converted options into 1,310 shares, increasing direct ownership by 6% to 21,884 units (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Director Kurzweil Ray converted options into 650 shares, increasing direct ownership by 5% to 13,320 units (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Director Mesa Nilda converted options into 650 shares, increasing direct ownership by 13% to 5,678 units (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Director Olian Judy D. converted options into 1,310 shares, increasing direct ownership by 31% to 5,555 units (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Director Patusky Christopher converted options into 650 shares, increasing direct ownership by 44% to 2,140 units (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Director Sullivan Louis W converted options into 650 shares, increasing direct ownership by 28% to 2,983 units (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $5,173,660 worth of shares (9,500 units at $544.60) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Director Malcolm Jan converted options into 650 shares and sold $178,942 worth of shares (325 units at $550.59) as part of a pre-agreed trading plan, increasing direct ownership by 260% to 450 units (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $5,235,756 worth of shares (9,500 units at $551.13) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $5,255,111 worth of shares (9,500 units at $553.17) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $5,309,296 worth of shares (9,500 units at $558.87) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A exercised 9,500 shares at a strike of $135.42 and sold $5,215,133 worth of shares (9,500 units at $548.96) as part of a pre-agreed trading plan (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)
- Chairperson & CEO Rothblatt Martine A sold $5,268,781 worth of shares (9,500 units at $554.61) as part of a pre-agreed trading plan and exercised 9,500 shares at a strike of $135.42 (SEC Form 4)4 - UNITED THERAPEUTICS Corp (0001082554) (Issuer)